Abstract
Preliminary evidence is presented suggestive of antitumor immunity, cross reactive with allogeneic extracts from tumors of the same type, and serum-blocking factor(s), which appear to be specific to autologous tumor only, in patients with prostatic cancer employing the method of leukocyte adherence inhibition.
Original language | English (US) |
---|---|
Pages (from-to) | 314-316 |
Number of pages | 3 |
Journal | Urology |
Volume | 9 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1977 |
Externally published | Yes |
ASJC Scopus subject areas
- Urology